CJC 1295 with DAC (Drug Affinity Complex) 5mg lyophilized peptide for in vitro research. A modified GHRH analog conjugated with a maleimido-DAC moiety for enhanced albumin binding affinity. Studied for GHRHR receptor binding kinetics, DAC-albumin interaction assays, and comparative cAMP signaling studies in cell-based models. For in vitro research use only — not for human or veterinary use. Specifications: - Quantity: 5mg - Form: Lyophilized Powder - Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys-(Mal-)-NH₂ - Purity: >99% (HPLC Verified) - Molecular Weight: ~3647.19 g/mol Intended Use: Strictly for in vitro laboratory research. Not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics. This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All sales are final. Buyer assumes full responsibility for safe handling and regulatory compliance.